BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PARI Pharma 

Steinerstrasse 15A

Munich    D-81369  Germany
Phone: 49-89-742-84669 Fax: 49-89-742-84650


SEARCH JOBS




Industry
Pharmaceutical






 Company News
PARI Pharma's Altera Delivers Gilead Sciences, Inc. (GILD)'s Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 6/21/2010 11:08:20 AM    More...
PARI Pharma Enrolls First Patient in Phase 2b Study of L-CsA 2/11/2010 10:29:56 AM    More...
PARI Pharma's Altera Delivers Gilead Sciences, Inc. (GILD)'s Cayston, Approved by European Commission to Treat Cystic Fibrosis 9/24/2009 8:45:06 AM    More...
Mpex Pharmaceuticals, Inc. Reports Positive Phase II Results with Aeroquin, Delivered by PARI Pharma's eFlow Technology 9/15/2009 7:59:58 AM    More...
PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans 6/3/2009 8:24:14 AM    More...
PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 5/21/2009 10:48:34 AM    More...
PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 5/8/2009 11:28:44 AM    More...
PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 11/10/2008 11:55:17 AM    More...
PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 10/7/2008 9:22:11 AM    More...
PARI Pharma's eFlow Delivers Alnylam Pharmaceuticals (ALNY) RNAi Therapeutic in Phase II Study 4/17/2008 10:27:04 AM    More...
12